{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/214613303"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The key, says Bowman, is to use venture debt only when it makes sense ??? to reach an important milestone or inflection point, such as a clinical trial or a crucial research and development stage." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "cfo.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/277592664"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/214613303" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/336677565"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/214613303"] } } }
